Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Lifetime Brands Inc (LCUT)
NASDAQConsumer DiscretionaryFurnishings, Fixtures & AppliancesSnapshot 2026-11-04
$8.89+4.71%
Close 2026-11-04 · 1-day change
NASDAQConsumer DiscretionaryFurnishings, Fixtures & AppliancesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.08 → 1.07 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for LCUT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA reaches at least $53.5 million in 2026 | The company targets adjusted EBITDA near $56 million and adjusted EPS around $0.80. | Improving | Adjusted EBITDA falls below $53.5 million in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is an execution-led recovery story, not yet a durable earnings compounder, because the evidence still classifies earnings quality as loss-making. The 1–3 year thesis is intact, with recent financial performance in the top half of its industry, but the overall risk level remains elevated.
The valuation evidence points to LCUT being cheap versus peers, while the model’s expectations gap is negative, meaning expectations appear more demanding than the valuation comparison alone suggests. Pricing is tagged as justified, and no fragility gates fired, so the evidence does not indicate an especially fragile setup.
Near term, revenue and earnings execution has improved: first-half revenue increased year over year, and management raised adjusted EBITDA and adjusted diluted EPS guidance in Q2. Revenue guidance was reaffirmed, and trailing-twelve-month adjusted EBITDA was within the updated range, though the evidence rates delivery on that priority as mixed. The recent earnings beat and higher guidance support momentum, but a reversal in guidance would raise credibility concerns.
The multi-year thesis hinges on management delivering its 2026 revenue and earnings priorities and sustaining the recent improvement. Near term, guidance follow-through is a key swing factor, especially after the recent increase. Sector bellwethers’ results could also strengthen or weaken the broader Consumer Discretionary backdrop.
For the 1–3 year view, LCUT has improving execution and an intact thesis, but its loss-making profile and elevated risk leave delivery and guidance credibility central. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company targets adjusted EBITDA near $56 million and adjusted EPS around $0.80. |
| Intact |
| Adjusted EPS falls below $0.73 in FY26 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches at least $650 million in 2026 | A primary condition in Lifetime Brands Inc's published investment case. The stated target is >=650 USD_MILLIONS. | Intact | Revenue falls below $650 million in FY26 | Revenue: $141.569M FY2026-Q2; GAAP. Published target: >=650 USD_MILLIONS. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 2026141,569,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Second Quarter Financial Results: Consolidated net sales for the three months ended June 30, 2026 were $141.6 million, representing an increase of $9.7 million, or 7.4%, as compared to net sales of $131.9 million for the corresponding period in 2025.” “Adjusted EBITDA (1) was $92.0 million for the trailing twelve months ended June 30, 2026.” Revenue was $141.569 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
PE ratio remains below peer median of 17.27 | A supporting condition in Lifetime Brands Inc's published investment case. The stated target is <=17.27. | Intact | PE ratio rises above 17.27 | P/E (TTM): 3.74x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 20263.7353 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.83 → $1.07 · observed estimates
$0.68B → $0.69B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-07-25 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-07-26 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-07-27 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-07-28 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-07-29 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-07-30 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-07-31 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-08-01 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-02 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-08-03 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-08-04 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-08-05 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-08-06 | $0.83 | $683,777,000 | 3 / 3 |
| 2026-08-07 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-08 | $0.99 | $687,877,000 | 2 / 3 |
| 2026-08-09 | $0.99 | $687,877,000 | 2 / 3 |
| 2026-08-10 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-12 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-13 | $0.91 | $689,705,000 | 3 / 3 |
| 2026-08-14 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-15 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-16 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-17 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-18 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-19 | $0.83 | $683,769,567 | 2 / 2 |
| 2026-08-20 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-21 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-22 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-23 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-24 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-25 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-26 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-27 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-28 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-29 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-30 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-08-31 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-01 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-02 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-03 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-04 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-05 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-06 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-07 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-08 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-09 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-10 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-11 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-12 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-13 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-14 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-15 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-16 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-17 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-18 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-19 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-20 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-21 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-22 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-23 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-24 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-25 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-26 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-27 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-28 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-29 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-09-30 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-10-01 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-10-02 | $0.91 | $689,688,567 | 2 / 2 |
| 2026-10-03 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-04 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-05 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-06 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-07 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-08 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-09 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-10 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-11 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-12 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-13 | $1.08 | $693,807,500 | 2 / 2 |
| 2026-10-14 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-15 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-16 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-17 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-18 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-19 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-20 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-21 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-22 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-23 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-24 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-25 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-26 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-27 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-28 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-29 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-30 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-10-31 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-11-01 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-11-02 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-11-03 | $1.07 | $692,810,000 | 2 / 2 |
| 2026-11-04 | $1.07 | $692,810,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.